Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/11/2018 06/12/2018 06/13/2018 06/14/2018 06/15/2018 Date
97.37(c) 96.45(c) 98.87(c) 100.8(c) 100.08(c) Last
4 829 970 7 204 162 6 597 770 6 733 401 12 895 664 Volume
-1.09% -0.94% +2.51% +1.95% -0.71% Change
More quotes
Financials (EUR)
Sales 2018 35 560 M
EBIT 2018 7 094 M
Net income 2018 5 068 M
Debt 2018 12 910 M
Yield 2018 2,78%
Sales 2019 37 834 M
EBIT 2019 8 035 M
Net income 2019 5 540 M
Debt 2019 9 472 M
Yield 2019 2,94%
P/E ratio 2018 18,11
P/E ratio 2019 16,18
EV / Sales2018 2,99x
EV / Sales2019 2,72x
Capitalization 93 330 M
More Financials
Company
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro.The Pharmaceuticals segment engages in... 
Sector
Pharmaceuticals
Calendar
09/05Earnings Release
More about the company
Surperformance© ratings of Bayer
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER
06/15BAYER : Japan suspends sale of Canadian wheat after GMO wheat found in Alberta
RE
06/15BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
06/15BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
06/15BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
06/14BAYER : Recent Findings from F. Kanefendt and Co-Authors Yields New Data on Phar..
AQ
06/14Bayer begins Rs 1.3K cr offer to buy stake in Monsanto
AQ
06/14BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
06/13BAYER : Federal Register Extracts
AQ
06/13BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
06/13BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
More news
Sector news : Pharmaceuticals - NEC
06/16International fund managers turn to financials, tech as trade worries rise
RE
06/15UK's Indivior will fight U.S. FDA's approval for copycat drug
RE
06/15Indivior Shares Drop After U.S. Approves Suboxone Generics
DJ
06/15UK's Indivior to seek injunction after rival gets FDA approval for generics
RE
06/15NOVARTIS : Study Shows Jakavi Reduces Blood Clots, Risk of Death
DJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER 
BAYER - 04/04
A trend reversal is in sight
BUY
BAYER - 02/05
A pullback with significant trading volume
SELL
More Strategies
Latest Tweets
06:00aAparito raised $6M from Europe’s biggest pharmaceutical company, Germany’s Ba..
21
06/15Bayer : Japan suspends sale of Canadian wheat after GMO wheat found in Albert.. 
06/15Bayer given €120.00 PT by Jefferies Financial Group Inc. buy rating.  
06/14Bayer given €118.00 PT by Sanford C. Bernstein. buy rating.  
06/13Bayer Pig Symposium addresses key swine production topics  
More tweets
Qtime:274
News from SeekingAlpha
06/13Biotech industry group criticized for party featuring topless dancers 
06/11Merck KGaA's tepotinib successful two mid-stage liver cancer studies 
06/093 THINGS IN BIOTECH, JUNE 8 : Ascend Ye PARP Inhibitors 
06/08Risk Aversion Returns Ahead Of Tense G7 Summit; China's US Trade Surplus Jump.. 
06/08WALL STREET BREAKFAST : Risk Sentiment Sours Before G7 Summit 
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 116 €
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-2.22%108 347
JOHNSON & JOHNSON-12.21%328 858
PFIZER-0.17%212 690
NOVARTIS-8.25%193 446
ROCHE HOLDING LTD.-14.06%183 969
MERCK AND COMPANY10.24%166 880